
Amanta Healthcare Limited IPO
Amanta Healthcare Limited IPO is a Mainboard book building IPO. Price band is ₹120 to ₹126 per share. Minimum investment is ₹14,994. Lot size is 119 shares. Open from 1 Sept 2025 to 3 Sept 2025. Allotment on 4 Sept 2025. Listing on 9 Sept 2025 at BSE, NSE. Managed by Beeline Capital Advisors Pvt.Ltd. Registrar: MUFG Intime India Private Limited (Link Intime). Key details for GMP, subscription, price, allotment, and listing in one place.
Amanta Healthcare Limited IPO overview
Amanta Healthcare Limited IPO Key figures
Price band, lot, minimum application, and issue window at a glance.
Amanta Healthcare Limited IPO important dates
Amanta Healthcare Limited IPO lot size
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 119 | ₹14,994 |
| Retail (Max) | 13 | 1,547 | ₹1,94,922 |
| S-HNI (Min) | 14 | 1,666 | ₹2,09,916 |
| S-HNI (UPI) | 33 | 3,927 | ₹4,94,802 |
| S-HNI (Max) | 66 | 7,854 | ₹9,89,604 |
| B-HNI (Min) | 67 | 7,973 | ₹10,04,598 |
About Amanta Healthcare Limited IPO
From the company / RHP narrative.
The company manufactures fluid therapy formulations, including IV fluids, diluents, ophthalmic solutions, and respiratory care products. It also offers irrigation solutions, first-aid products, and eye lubricants in the medical device segment.
The company markets products through three business units:
National sales,
International sales and
Product partnering with various foreign and Indian pharmaceutical companies.
The company manufactures over 45 generic products, marketing them under their brands in India through 320 distributors and stockists.
The company sells products in Africa, Latin America, the UK, and beyond. Its products are registered in 19 countries and comply with various regulations. In Fiscal 2025, the company exported branded products to 21 countries.
As of March 31, 2025, the company has a team of 1,718 employees at its formulation and development and quality laboratory.
Competitive Strengths
Well-established manufacturer of pharmaceutical formulations with a diverse product portfolio and diverse market.
Large manufacturing capabilities
Wide Domestic and International Marketing Network.
Experienced management team supported by a large, diverse and skilled workforce.
Objective of the issue
How the issuer plans to use IPO proceeds.
Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat
General corporate purposes
Ratings & reviews
Community ratings and reviews — not financial advice.
No ratings yet — be the first to share your experience.
Follow the latest IPO & unlisted research on iOS and Android.
Documents & links
Prospectus, draft filings, and company site open in a new tab.
Registrar
Details about the registrar of the issue.
Issue details
Key details about the issue, including the face value, lot size, and minimum investment.
Related articles
Research posts and updates that reference this company or theme.
Follow the latest IPO & unlisted research on iOS and Android.